NOVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Novanta Inc (NOVT) is not a strong buy at the moment for a beginner, long-term investor. While the company shows some positive financial growth and hedge fund interest, the technical indicators are neutral, and there are no significant catalysts or proprietary trading signals to suggest immediate action. The stock may be worth monitoring for a better entry point.
The MACD is below 0 and negatively contracting (-0.347), indicating bearish momentum. RSI is neutral at 43.779, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level (117.82), with resistance at 122.232 and support at 113.408.
Hedge funds have increased their buying activity by 140% in the last quarter. Analyst Robert Mason raised the price target to $150, suggesting confidence in future sales and margin acceleration.
No significant insider trading trends. Gross margin and EPS have declined YoY. Technical indicators do not suggest a strong upward trend. No recent news or congress trading activity to drive momentum.
In Q4 2025, revenue increased by 8.52% YoY to $258.35M, and net income rose by 6.12% YoY to $17.47M. However, EPS dropped by 2.17% YoY to 0.45, and gross margin declined by 4.71% YoY to 40.7%.
Analyst Robert Mason from Baird raised the price target from $138 to $150 while maintaining a Neutral rating. This reflects cautious optimism about the company's future performance.
